Materialise NV
MTLSNASDAQTechnologySoftware - Application

About Materialise NV

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Company Information

CEOBrigitte de Vet-Veithen
Founded1990
IPO DateJune 25, 2014
Employees488
CountryBelgium
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyEUR - EUR
TypeStock

Contact Information

Phone32 1 639 66 11
Address
Technologielaan 15 Leuven, 3001 Belgium

Corporate Identifiers

CIK0001091223
CUSIP57667T100
ISINUS57667T1007
SIC7372

Leadership Team & Key Executives

Brigitte de Vet-Veithen
Chief Executive Officer
Wilfried Vancraen
Founder and Chairman
Koen Berges
Chief Financial Officer
Johan Pauwels
Executive Vice President and Chief Operating Officer
Bart Van der Schueren
Chief Strategy and Technology Officer and Executive Vice President
Carla Van Steenbergen
Director of Corporate Affairs, Vice President, Compliance Officer and Secretary
Jurgen Laudus
Executive Vice President of Manufacturing
Udo Eberlein
Executive Vice President of Software
Koen Peters
Executive Vice President of Medical